Literature DB >> 9707077

Esophagogastric fistula: a complication of Crohn's disease--case report and review of the literature.

J C Rholl1, R T Yavorski, C P Cheney, R K Wong.   

Abstract

Esophagogastric fistula formation as a complication of esophageal Crohn's has been reported in only one case in the literature. In addition, only eight cases of esophageal fistulae of any type have been reported in the setting of Crohn's disease. Unlike the more often described superficial, aphthous disease of the esophagus, response of fistulae to medical therapy has been disappointing, and recurrence and progression are likely. Surgery remains the primary modality for refractory disease. The roles of salicylates, antibiotics, immunosuppressive agents, sealants, and intralesional steroid injections have not been well defined. We present a case of severe, refractory Crohn's disease with fistula formation between the esophagus and stomach, and concomitant involvement of the oropharynx, duodenum, terminal ileum, and cecum.

Entities:  

Mesh:

Year:  1998        PMID: 9707077     DOI: 10.1111/j.1572-0241.1998.428_i.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

1.  Successful treatment of refractory esophageal Crohn's disease with infliximab.

Authors:  D S Fefferman; S A Shah; M Alsahlil; A Gelrud; K R Falchulk; R J Farrell
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

Review 2.  Crohn's Disease of the Esophagus, Duodenum, and Stomach.

Authors:  David M Schwartzberg; Stephen Brandstetter; Alexis L Grucela
Journal:  Clin Colon Rectal Surg       Date:  2019-06-17

3.  Esophageal Crohn's disease treated "topically" with swallowed aerosolized budesonide.

Authors:  Petros Zezos; Georgios Kouklakis; Anastasia Oikonomou; Michail Pitiakoudis; Constantinos Simopoulos
Journal:  Case Rep Med       Date:  2010-09-30

4.  Isolated Crohn's disease of the esophagus with esophago-mediastinal fistula formation.

Authors:  Wuping Wang; Yunfeng Ni; Changkang Ke; Qingshu Cheng; Qiang Lu; Xiaofei Li
Journal:  World J Surg Oncol       Date:  2012-10-03       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.